None listed
Conditions
Brief summary
The use of 3D visualisation technologies, including virtual reality and 3D printing, will improve education for patients and families with children with congenital heart disease. These technologies provide benefits for visualisation of congenital heart disease when compared to the current practice of using drawings and diagrams. This will enable better understanding of the congenital defects, with other benefits including alleviating anxiety around the disease and understanding the surgical and interventional management.
Interventions
The proposed study is a parallel, randomised controlled trial comparing 3D visualisation tools when providing education to patients and families, comparing to the current practice of 2D diagrams. The participants are adolescents and young adult patients with congenital heart disease, or the parent/legal guardian of a paediatric patient with congenital heart disease, where the patient has received cross-sectional imaging (cardiac CT or MRI) as a part of their routine care under the Paediatric Cardiology team at Starship Children’s Hospital. The intervention will be conducted within the Cardiology Department at Starship Children's Hospital. Participants will be randomly allocated into one of three groups by computer generation, determining which education tool they will see first: Arm 1: 2D Diagram (control) An illustration of the patient's type of congenital heart disease is presented to the participant with direction from the Cardiology Advanced Trainee. Arm 2: 3D Printed Model An individualised resin 3D print of the patient's heart is presented to the participant with direction from the Cardiology Advanced Trainee Arm 3: Virtual Reality model An individualised VR model of the patient's heart is presented through the Meta Quest 3 VR headset. The participant will apply the headset and will be guided through the model with instruction from the Cardiology Advanced Trainee providing the education. The education will be delivered in face-to-face sessions by senior Paediatric Cardiology Advanced Trainees to the participant followed by a questionnaire, in total this is expected to take 1 hour. Participants will be approached for consent and enrolment at the time of their imaging appointment or at the next outpatient appointment, and the education and questionnaire will be performed at that time.
Sponsors
Study design
Eligibility
Inclusion criteria
Paediatric patients (aged 16 years or under at time of study) or parent/guardian of a patient (aged 16 years or under at time of study) AND - Patient has a clinical diagnosis of congenital heart disease AND - Recent cross-sectional imaging (cardiac CT or MRI) AND - Has provided informed consent to participate
Exclusion criteria
Critically unwell patients Participant has inadequate understanding of written and verbal English Patients who will not receive face-to-face outpatient follow up with our service within the study period